NutraNomics, Inc. announced the Company’s plans to begin development on a new line of CBD products to add to their already successful, existing line of nutraceutical offerings. The Company stated that after reviewing and numerous successful laboratory study results, the Company is currently seeking strategic partnerships to source raw materials and begin the process of developing, manufacturing and bringing a high-quality CBD product to market. Current CBD research has shown tremendous success in dealing with anxiety reduction, depression, heart health, athletic recovery, diabetes prevention as well as assisting in the recovery process for various illnesses and injuries including cancer. NutraNomics will continue to sell and promote its products through multiple distribution, manufacturing and marketing agreements it has successfully reached, thereby continuing its rapid growth.